(Reuters) – The European Medicines Agency (EMA) said on Monday Eli Lilly & Co’s Trulicity, which treats type 2 diabetes in children above 10 years of age, will continue to remain in shortage in Europe through September.
(Reporting by Khushi Mandowara in Bengaluru; Editing by Devika Syamnath)
